Chemokine Therapeutics (fka CHKT)

[roelien]

British Canadian Bioscience corp (a private BC biotechnology company) and CHKT has the same CEO and Science directors, Mr Korz and Mr Wong and also the same IP of CHKT is on the BSBP website, the 28 issued and 9 pending patents for:

1. Therapeutics for chemokine mediated diseases
2. CXCR4 antagonist treatment of hematopoeitic cells
3. Bicyclic aromatic chemokine receptor ligands
4. Therapeutic chemokine receptor antagonists
5. Cyclic peptides for modulating growth of neovessels and their use in therapeutics angiogenesis
6. Novel chemokine mimetics synthesis and their use
7. DNA encoding for recombinant polypeptide mutants of human SDF-1

Link to

http://www.bcbcorp.net/IntellectualProperty.html

Product Pipeline;

1.CTCE-9908 (Anti-Metastasis and Anti-Cancer)

2. CTCE-0214 (Hematological Support; mobilization of stem cells and neutrophils into the circulation)

3.CTCE-0324 (Peripheral Vascular Disease)